CALMA BTA B — Calmark Sweden AB Income Statement
0.000.00%
Last trade - 00:00HealthcareBalancedMicro Cap
- SEK16.83m
- SEK15.19m
- SEK0.06m
Annual income statement for Calmark Sweden AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0.221 | 0.057 |
| Cost of Revenue | |||||
| Gross Profit | — | — | — | 8.01 | -3 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 5.15 | 7.63 | 10.7 | 22.4 | 48.2 |
| Operating Profit | -5.15 | -7.63 | -10.7 | -22.2 | -48.2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -5.36 | -7.79 | -10.8 | -22.2 | -48.2 |
| Net Income After Taxes | -5.36 | -7.79 | -10.8 | -22.2 | -48.2 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -5.36 | -7.79 | -10.8 | -22.2 | -48.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -5.36 | -7.79 | -10.8 | -22.2 | -48.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.333 | -0.249 | -0.252 | -0.459 | -0.584 |
| Dividends per Share |